Promega Corporation
Home » Products + Services » Cell Health Assays »

Cell Viability Assays

glomaxInstrumentsBanner

Related Products

Latest Cell Viability Assays Articles

Video

ddOverview-thumbLearn about cancer drug discovery with Promega cell-based assays.

Need Assistance? Chat

Mitochondrial Function_6601MA
Reliable Cell Viability Resources

Quantifying cell viability is crucial for understanding cancer biology, compound toxicity and cellular response to cytokines and other biological questions. Promega offers tools for monitoring general cell viability as well as assays that help determine the mechanism of cell death. Biomarkers that can be quantified include ATP, NADH, Capases, LDH, and live- and dead-cell proteases.

Featured Products

MultiTox Multiplex Assays

Control variability by quantifying the number of live and dead cells within a single well.

CellTiter-Glo® Assay

Directly measure the key energy metabolite ATP, resulting in sensitive quantitation of the number of healthy cells in culture using this simple assay.

CellTiter 96® AQueous One Solution Cell Viability Assay

A colorimetric method for determining the number of viable cells in proliferation, cytotoxicity or chemosensitivity assays.

CellTiter-Fluor™ Cell Viability Assay

A nonlytic, single-reagent-addition fluorescence assay that measures the relative number of live cells in a culture by quantitating a conserved "live-cell" protease activity.

Featured Resources

PAG_CellViability_fr Cell Viability

This chapter of the Protocols and Applications Guide describes the various cell viability assays and helps you chose the right method for your needs.

PAG_fr Apoptosis

This chapter of the Protocols and Applications Guide explains the molecular mechanisms of apoptosis, how to confirm apoptosis, and the use of multiplexed assays using a single sample.

Promega

About Us

Connect With Us

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.